Maqui and Chronic Kidney Disease: A Narrative Review on the Potential Nephroprotective Role of Anthocyanins
Nutrients · 2025
DOI: 10.3390/nu17061058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Caterina Tiscornia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Nutrición y Dietética, Universidad Finis Terrae, Santiago 7501014, Chile. Hauptthemen laut MEDLINE: Anthocyanins, Renal Insufficiency, Chronic, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Chronic kidney disease (CKD) is a progressive pathology, with high global prevalence, associated with inflammation and oxidative stress. Given the limited capacity of conventional treatments to reverse renal damage, complementary alternatives have emerged such as supplementation with anthocyanins from maqui (Aristotelia chilensis), known for their antioxidant and anti-inflammatory properties. This review analyzes the evidence for their impact on CKD progression.
Methods
A narrative review of the experimental literature regarding maqui anthocyanins, their bioavailability, and their effects on oxidative stress, inflammation, and CKD to January 2025 was conducted. Articles without peer review or without a focus on Aristotelia chilensis were excluded, guaranteeing an updated compilation on its nephroprotective potential.
Results
Anthocyanins have shown benefits in reducing oxidative stress, inflammation, and glycemia regulation. Preclinical studies suggest improvements in renal function as well as less fibrosis. Human trials indicate positive effects on metabolism, although evidence in CKD patients is limited. Bioavailability remains a challenge to optimizing efficacy.
Conclusions
Maqui is a promising source of anthocyanins, with nephroprotective potential. However, robust clinical studies are required to determine its safety, optimal dose, and long-term impact in CKD. Its incorporation into evidence-based therapeutic strategies could offer an innovative approach in the management of this disease. More clinical studies are needed to validate the preclinical findings and optimize the therapeutic use of maqui in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Nutrición y Dietética, Universidad Finis Terrae, Santiago 7501014, Chile.
- Escuela de Enfermería, Universidad Finis Terrae, Santiago 7501014, Chile.
- Escuela de Kinesiología, Facultad de Arte y Educación Física, Universidad Metropolitana en Ciencias de la Santiago, Santiago 7760197, Chile.
- Unidad de Diálisis, Clínica Indisa, Santiago 7501014, Chile.
ORCID-Profile: Violeta Tapia, Daniela Águila, Enrique Lorca-Ponce
Zitieren
APA
Tiscornia, C., Tapia, V., Águila, D., Lorca-Ponce, E., Aicardi, V., & Vásquez, F. (2025). Maqui and Chronic Kidney Disease: A Narrative Review on the Potential Nephroprotective Role of Anthocyanins. Nutrients. https://doi.org/10.3390/nu17061058
Vancouver
Tiscornia C, Tapia V, Águila D, Lorca-Ponce E, Aicardi V, Vásquez F. Maqui and Chronic Kidney Disease: A Narrative Review on the Potential Nephroprotective Role of Anthocyanins. Nutrients. 2025. doi:10.3390/nu17061058
BibTeX
@article{Tiscornia2025,
author = {Tiscornia, Caterina and Tapia, Violeta and Águila, Daniela and Lorca-Ponce, Enrique and Aicardi, Valeria and Vásquez, Fabián},
title = {Maqui and Chronic Kidney Disease: A Narrative Review on the Potential Nephroprotective Role of Anthocyanins},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17061058}
}
EUVIMED